Pharmaceuticals

Biopharmaceutical Excipient Manufacturing Market Size, Share & Trends Analysis Report By Product Type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Excipients), By Type of Biologics, By Scale Of Operation, By Region, And Segment Forecasts, 2025-2034

The Biopharmaceutical Excipient Manufacturing Market Size is valued at 2.73 Billion in 2024 and is predicted to reach 4.38 Billion by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Increasing need for generic drugs and pharmaceutical products is driving the biopharmaceutical excipient manufacturing market. Technological advancements in bioprocessin...

Report ID: 1197  |  

Delivery: Immediate  |  

Published: March 2025   |  

No. of Pages: 190

Ischemic Heart Disease (IHD) Drugs Market Size, Share & Trends Analysis Report, By Disease class (angina pectoris, myocardial infarction), By Drug Class (Anti-dyslipidemic drugs, calcium channel blockers, beta-blockers, ACE inhibitors, arbs, vasodilators, antithrombotic agents), By Region, Forecasts, 2024-2031

Ischemic Heart Disease (IHD) Drugs Market Size was valued at USD 6.07 Bn in 2023 and is predicted to reach USD 8.46 Bn by 2031 at a 4.4% CAGR during the forecast period for 2024-2031. Ischemic heart disease (IHD) drugs are those that treat situations where the heart does not receive enough blood, most often because the coronary arteries are too small or too clogged. Some of these medications can alleviate chest pain, lower cholesterol, reduce ...

Report ID: 2506  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Pediatric MRI Market Size, Share & Trends Analysis Report By Type (Functional Brain MRI, Cardiac MRI, 4D MRI, and Others), Product Type (Equipment, Coil Design), Age Group, Application, and End User, Region And Segment Forecasts, 2023-2031

The Global Pediatric MRI Market Size is valued at USD 3.57 billion in 2022 and is predicted to reach USD 6.62 billion by the year 2031 at a 7.3% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: There is growing awareness among healthcare professionals and parents about the importance of early diagnosis and intervention in pediatric diseases. MRI is extensively used in pediatr...

Report ID: 2043  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use, By Region, And By Segment Forecasts, 2024-2031

The Latent Tuberculosis Infection Detection Market Size is valued at USD 1.53 billion in 2023 and is predicted to reach USD 2.37 billion by the year 2031 at a 5.7% CAGR during the forecast period for 2024-2031. Latent tuberculosis infection (LTBI) detection is a critical component of tuberculosis (TB) control, aiming to prevent the progression to active TB disease. Regular screening and effective detection strategies are vital for reducing TB ...

Report ID: 2579  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 175

Molecular Forensics Market Size, Share & Trends Analysis Report By Product (Kits and Consumables, Instruments, Software and Other Products), By Technology, By Application, By End-User, By Region, And By Segment Forecasts, 2024-2031

The Molecular Forensics Market Size is valued at 1351.86 Million in 2023 and is predicted to reach 3099.92 Million by the year 2031 at a 11.18 % CAGR during the forecast period for 2024-2031.  Key Industry Insights & Findings from the Report: Technological advancements in diagnostics and the implementation of efficient and effective methods to meet rising consumer demand are driving market growth. Rising security concerns ...

Report ID: 1378  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 175

Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Anti-Parasite, Antifungal, Antibiotics, Others), By Disease Type (Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Others), By Distribution Channel (Direct Sales, Indirect Sales), By Region, And By Segment Forecasts, 2024-2031

The Neglected Tropical Disease Treatment Market Size is valued at USD 2.9 billion in 2023 and is predicted to reach USD 4.4 billion by the year 2031 at a 5.3% CAGR during the forecast period for 2024-2031. Neglected tropical disease treatment describes medical approaches and activities, such as medication, vaccinations, and public health campaigns, that are intended to address infectious diseases that largely impact underprivileged communities...

Report ID: 2928  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 170

Monkeypox Vaccine And Treatment Market Size, Share & Trends Analysis Report By Product (Vaccine, Drugs, Vaccinia Immune Globulin (VIG)), By Gender (Male, Female, Others), By Route of Administration, By End-Use, By Region, And By Segment Forecasts, 2024-2031

The Monkeypox Vaccine And Treatment Market Size is valued at 85.86 Million in 2023 and is predicted to reach 212.34 Million by the year 2031 at an 12.39 % CAGR during the forecast period for 2024-2031.  Key Industry Insights & Findings from the Report: Increase in the prevalence of monkeypox is driving the monkeypox vaccine and treatment market. Increasing in the demand for vaccines as well as new treatment for monkeypox i...

Report ID: 1394  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Allogeneic Stem Cell Transplantation Market Size, Share & Trends Analysis Report By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, and Others), By Application (Cancer, Autoimmune Diseases, Blood Disorders, Cardiac Disorders, Neurological Disorders, Diabetes, and Others), By End User (Hospitals, Research Institutes, Specialty Clinics, and Others), By Cell Type, By Region, And By Segment Forecasts, 2023-2031.

Allogeneic Stem Cell Transplantation Market Size is valued at USD 3.66 Bn in 2022 and is predicted to reach USD 6.75 Bn by the year 2031 at a 7.21% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: The market is propelled by increased incidence of chronic illnesses such cancer, autoimmune diseases, and blood disorders. Over the past ten years, there has been a consistent rise in the number of...

Report ID: 2241  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 179

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Types (Surgical Clipping, Endovascular Coiling, Flow Diverters, Other Types), By End-User (Hospitals, Clinics, Other End-Users), By Region, And By Segment Forecasts, 2024-2031

The Intracranial Aneurysm Market Size is valued at USD 1.23 Billion in 2023 and is predicted to reach USD 2.50 Billion by the year 2031 at a 9.4% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The prevalence of intracranial aneurysms is rising due to factors such as ageing populations, lifestyle changes, and better diagnostic capabilities. These techniques offer shorter recovery times and...

Report ID: 1283  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 180

Oral Proteins and Peptides Market Share & Trends Analysis Report, By Type of Target Disease Indication (Acromegaly, Celiac Disease, Chronic Idiopathic Constipation, Enteric Hyperoxaluria, Inflammatory Bowel Disease, and Type II Diabetes), Type of Molecule (Protein and Peptide), Type of Biological Target, Type of Mechanism of Action, By Region, and Segment Forecasts, 2024-2031

The Oral Proteins and Peptides Market Size is valued at USD 6.51 Bn in 2023 and is predicted to reach USD 28.17 Bn by the year 2031 at an 20.3% CAGR during the forecast period for 2024-2031. Oral proteins and peptides are therapeutic medicines made from short chains of amino acids, designed for oral administration to leverage their biological properties in treating various ailments. However, their bioavailability is limited due to degradation ...

Report ID: 2868  |  

Delivery: Immediate  |  

Published: February 2025   |  

No. of Pages: 170